Compare · HPQ vs OMCL
HPQ vs OMCL
Side-by-side comparison of HP Inc. (HPQ) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HPQ and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- HPQ is the larger of the two at $18.48B, about 9.4x OMCL ($1.96B).
- Over the past year, HPQ is down 18.4% and OMCL is up 32.9% - OMCL leads by 51.3 points.
- HPQ has been more active in the news (13 items in the past 4 weeks vs 6 for OMCL).
- HPQ has more recent analyst coverage (25 ratings vs 24 for OMCL).
- Company
- HP Inc.
- Omnicell Inc.
- Price
- $20.86+3.50%
- $41.51-3.61%
- Market cap
- $18.48B
- $1.96B
- 1M return
- +8.51%
- +24.43%
- 1Y return
- -18.41%
- +32.90%
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- News (4w)
- 13
- 6
- Recent ratings
- 25
- 24
HP Inc.
HP Inc. provides personal computing and other access devices, imaging and printing products, and related technologies, solutions, and services in the United States and internationally. The company operates through three segments: Personal Systems, Printing, and Corporate Investments. The Personal Systems segment offers commercial and consumer desktop and notebook personal computers, workstations, thin clients, commercial mobility devices, retail point-of-sale systems, displays and other related accessories, software, support, and services. The Printing segment provides consumer and commercial printer hardware, supplies, solutions, and services, as well as scanning devices. The Corporate Investments segment includes HP Labs and business incubation projects. HP Inc. serves individual consumers, small- and medium-sized businesses, and large enterprises, including customers in the government, health, and education sectors. The company was formerly known as Hewlett-Packard Company and changed its name to HP Inc. in October 2015. HP Inc. was founded in 1939 and is headquartered in Palo Alto, California.
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest HPQ
- Spring Into Gaming: HyperX Expands Its Gaming Peripherals and Software Ecosystem
- HP Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 4 filed by Yoon Songyee
- SEC Form 4 filed by Rucker Kim K.W.
- SEC Form 4 filed by Pettiti Gianluca
- SEC Form 4 filed by Miscik Judith A
- SEC Form 4 filed by Meline David W
- SEC Form 4 filed by Francisco Ma. Fatima
- SEC Form 4 filed by Clemmer Richard L
- SEC Form 4 filed by Citrino Mary Anne
Latest OMCL
- Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer
- Omnicell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Omnicell Announces First Quarter 2026 Financial Results
- Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026
- SEC Form DEF 14A filed by Omnicell Inc.
- AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
- SEC Form 4 filed by Njoku Nnamdi
- SEC Form 4 filed by Manley Corey J
- SEC Form 4 filed by Nutt Brian H.
- SEC Form 4 filed by Radford Harlan Baird